Aslam Anis
Aslam H. Anis | |
|---|---|
| Born | April 29, 1959 |
| Nationality | Canadian |
| Alma mater | University of Dhaka, Carleton University |
| Known for | Health economics |
| Spouse | Janet Anis (née Disanjh) |
| Children | 2 |
| Awards | Fellow of the Canadian Academy of Health Sciences (2010) |
| Scientific career | |
| Fields | Health Economics, Health Services Research, Pharmacoeconomics |
| Institutions | University of British Columbia |
Aslam Anis is a Bangladeshi-Canadian health economist whose primary areas of research involvement include health services research, measuring patient-reported outcomes, Canadian competition policy in the pharmaceutical industry, and the cost-effectiveness of treatments for HIV/AIDS, rheumatoid arthritis, and other conditions.[1][2][3]
Biography
[edit]Early life
[edit]Aslam Hayat Anis was born in Dhaka, Bangladesh (then known as Dacca, East Pakistan) to a Bengali family. His father Anis Waiz (1935 – 2003) was a professor of medicine and founding principal of Bangladesh Medical College.[4] Anis's mother, Rokaiya Anis (née Ahad) (1935 – 2018), was a clinician in gynaecology and obstetrics who participated in the 1952 Language Movement. She joined the Pakistan Army as a civilian medical officer and later ran the gynaecology and obstetrics department at the Combined Military Hospital.[5]
Academic career
[edit]Anis completed his BSS (Honours) in economics at the University of Dhaka (1981) and his MA and PhD in economics at Carleton University (1983, 1990). He joined the faculty of the University of British Columbia Faculty of Medicine, School of Population and Public Health (then called the Department of Health Care & Epidemiology) in 1995. He was appointed as a full professor in the school in 2005. From 2002 to 2013, Anis served as the director of the Masters of Health Administration (MHA) program in the UBC Faculty of Medicine. He is the National Co-Director of the CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research (CTN+) and the Director of the Centre for Health Evaluation and Outcome Sciences in Vancouver, British Columbia.[3] Anis is currently the Director of the School of Population and Public Health at UBC.[6]
Research
[edit]Anis's research spans several areas, including pharmaceutical pricing and regulation, pharmacoeconomic policy, economic decision analysis, measure of work productivity, arthritis, HIV/AIDS, and addictions research. His work has been used to shape economic and health policies across Canada.[7][2]
His earliest research in the pharmaceuticals showed that pricing regulations of drug plans were responsible for higher generic drug prices in Canada. In 1995, as the founding director of the Pharmacoeconomic Initiative of BC, Anis developed a framework under which firms seeking to list drugs on the provincial formulary were required to submit cost-effectiveness data in order to inform the government's funding decision.[8][9]
Anis was among the first scholars worldwide to demonstrate the cost-effectiveness of anti-retroviral therapy for HIV. This work changed policies governing access to this critical treatment for persons living with HIV/AIDS in British Columbia.[7][10]
He led the health economic analysis for North American Opiate Management Initiative (NAOMI) clinical trial[11] and the Study to Assess Longer-term Opioid Medication Effectiveness (SALOME) clinical trial.[12] These clinical trials were the first of their kind in North America and demonstrated the safety, efficacy, and cost-effectiveness of injectable diacetylmorphine (medical-grade heroin) and hydromorphone (Dilaudid) in treating people with long-term opioid use disorder.[12][13][14] In response to this research and other work, the Canadian government amended regulations to improve access to medically prescribed injectable opioids.[15]
Honours, decorations, awards and distinctions
[edit]In 2010, Anis was appointed as a Fellow of the Canadian Academy of Health Sciences.[16]
References
[edit]- ^ "Aslam Anis". CHEOS: Centre for Health Evaluation & Outcome Sciences. Archived from the original on 2016-03-17. Retrieved 2020-04-07.
- ^ a b "Aslam Anis". Arthritis Research Canada. Retrieved 2020-11-03.
- ^ a b "Aslam Anis". School of Population and Public Health (SPPH). Retrieved 2020-11-03.
- ^ "Recalling Major General Anis Waiz". Daily Sun. Retrieved 2020-11-03.
- ^ "Language Movement veteran Dr Col Rokaiya Anis passes away". Daily Sun. Retrieved 2020-11-03.
- ^ "SPPH Welcomes New Director Dr. Aslam Anis". School of Population and Public Health (SPPH). 2021-03-09. Retrieved 2021-03-15.
- ^ a b "Anis, Aslam". CanHepC - Canadian Network on Hepatitis C. Retrieved 2020-11-03.
- ^ Anis, Aslam H.; Wen, Quan (1998-01-01). "Price regulation of pharmaceuticals in Canada". Journal of Health Economics. 17 (1): 21–38. doi:10.1016/S0167-6296(97)00016-7. ISSN 0167-6296. PMID 10176313.
- ^ "OHE Welcomes Dr. Aslam Anis". www.ohe.org. 2015-01-28. Retrieved 2020-11-03.
- ^ Anis, Aslam H.; Guh, Daphne; Hogg, Robert S.; Wang, Xiao-Hua; Yip, Benita; Craib, Kevin J. P.; O’Shaughnessy, Michael V.; Schechter, Martin T.; Montaner, Julio S. G. (2000-10-01). "The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS". PharmacoEconomics. 18 (4): 393–404. doi:10.2165/00019053-200018040-00007. ISSN 1179-2027. PMID 15344307. S2CID 20186375.
- ^ Luba, Frank. "Why a B.C. doctor says heroin may be better than methadone for addicts". The Province. Retrieved 2020-11-03.
- ^ a b Bansback, Nick; Guh, Daphne; Oviedo-Joekes, Eugenia; Brissette, Suzanne; Harrison, Scott; Janmohamed, Amin; Krausz, Michael; MacDonald, Scott; Marsh, David C.; Schechter, Martin T.; Anis, Aslam H. (2018). "Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial". Addiction. 113 (7): 1264–1273. doi:10.1111/add.14171. ISSN 1360-0443. PMID 29589873. S2CID 4382466.
- ^ Oviedo-Joekes, Eugenia; Brissette, Suzanne; Marsh, David C.; Lauzon, Pierre; Guh, Daphne; Anis, Aslam; Schechter, Martin T. (2009-08-20). "Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction". New England Journal of Medicine. 361 (8): 777–786. doi:10.1056/NEJMoa0810635. ISSN 0028-4793. PMC 5127701. PMID 19692689.
- ^ Oviedo-Joekes, Eugenia; Guh, Daphne; Brissette, Suzanne; Marchand, Kirsten; MacDonald, Scott; Lock, Kurt; Harrison, Scott; Janmohamed, Amin; Anis, Aslam H.; Krausz, Michael; Marsh, David C. (2016-05-01). "Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence". JAMA Psychiatry. 73 (5): 447–55. doi:10.1001/jamapsychiatry.2016.0109. ISSN 2168-622X. PMID 27049826.
- ^ Mar 26, Kyle Duggan Published on; 2018 9:39am (2018-03-26). "Health Canada speeding up access to prescription heroin, methadone". iPolitics. Retrieved 2020-11-03.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ^ "CAHS Fellows Directory – Canadian Academy of Health Sciences | Académie canadienne des sciences de la santé". Retrieved 2020-11-03.